Sign in

CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company

Alaunos Therapeutics, Inc.

Sign in to watch
Ticker
TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
841475642
Phone
(346) 355-4099
Business address
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
Former names
ZIOPHARM ONCOLOGY INC, EASYWEB INC
  1. 3 Insider Initial Statement of Ownership
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. 8-K Event Executive or director change
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  8. 4 Grant or award EVP, GM Gene Therapy acquired 31,500 shares (grant or award)
  9. 4 Grant or award Chief Legal Officer and Sec. acquired 43,500 shares (grant or award)
  10. 4 Grant or award Interim CEO acquired 90,000 shares (grant or award)
  11. 4 Grant or award EVP, GM Cell Therapy acquired 50,825 shares (grant or award)
  12. 8-K Event Executive or director change
  13. 10-K Report Annual Report
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Results of operations
  16. 8-K Event Executive or director change
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit

Page 15 of 65 · 1,296 filings